Actively Recruiting
Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs
Led by Institut Rafael · Updated on 2024-10-01
300
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Currently, aspects related to the effects of anticancer treatments and the quality of life of patients and their needs are still poorly documented at the Rafael Institute. Thus this study will meet a dual objective: (1) the establishment of a registry to collect data on the safety and effectiveness of innovative and expensive anticancer drugs when administered in real life and (2) a measurement quantitative quality of life of patients treated with these drugs.
CONDITIONS
Official Title
Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age equal to or greater than 18 years (adult)
- Patients treated with an anticancer drug included in the list of innovative/expensive therapies (protocol appendix)
- Patients benefiting from non-pharmacological treatment at the Rafael Institute
- Who understands the French language
You will not qualify if you...
- Younger than 18 years old
- Patient deprived of liberty, under guardianship or unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute Rafaël
Levallois-Perret, Institut Rafael, France, 92300
Actively Recruiting
Research Team
A
Alain TOLEDANO, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here